Connect with Omnipod® 5
Dexcom CGM and Omnipod® 5 are a great team because they can help keep you in range1, without tubes, multiple daily injections or fingersticks!*
*Fingersticks required for diabetes treatment decision if symptoms or expectations do not match readings. Pod shown without necessary adhesive.
Dexcom CGM + Omnipod 5 Automated Insulin Delivery System
Dexcom CGM and Omnipod 5 are in continuous communication, enabling automatic insulin adjustments.
SmartAdjust™ technology
With Dexcom CGM and Omnipod 5 communicating every 5 minutes, the system will help to correct high and protect from low glucose levels.2,3
Activity feature
Use the available Activity feature and Omnipod 5 to reduce insulin delivery when glucose typically goes low, like when exercising.
SmartBolus calculator
See your Dexcom CGM data and trend automatically incorporated into the built-in bolus calculator.
Seamless
1. Dexcom CGM— The wearable sensor takes glucose measurements and sends those numbers to your Pod and/or smart device‡ to let you know your current glucose numbers.
2. Pod— Tubeless, wearable, and waterproof**, the state-of-the-art Pod, with built-in SmartAdjust™ technology, sits right on your body and automatically adjusts insulin delivery based on your CGM readings to help keep you in range†.
3. Smart Device— See your glucose data in real time from the included Controller, compatible smartphone or smartwatch‡.
Meet Dexcom CGM
Meet Dexcom CGM, you have the freedom to choose the insulin pump that works best for you. Glucose readings are sent to your smartphone‡—without fingersticks.*
*Fingersticks required for diabetes treatment decision if symptoms or expectations do not match readings.
Do you have questions about Omnipod 5?
Our experts are here to help.
**The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Controller is not waterproof. †If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. ‡For a list of compatible smartphone devices for Omnipod 5 visit omnipod.com/compatibility. For a list of Dexcom compatible devices, visit www.dexcom.com/compatibility.
1 Brown S. et al. Diabetes Care. 2021;44:1630-1640. 2 Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs. 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults/adolescents and children, standard therapy vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. Brown et al. Diabetes Care (2021). 3 Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose (>180mg/dL) from CGM in standard therapy vs Omnipod 5 = 39.4% vs. 29.5%. Average time with low blood glucose (<70mg/dL) from CGM in standard therapy vs Omnipod 5 = 3.41% vs. 2.13%. Sherr JL, et al. Diabetes Care (2022). Omnipod and SmartAdjust are trademarks or registered trademarks of Insulet Corporation in the United States of America and other various jurisdictions and are used with permission. All rights reserved.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.